Cargando…

Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation

Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingo...

Descripción completa

Detalles Bibliográficos
Autores principales: Horváth, Ádám, Payrits, Maja, Steib, Anita, Kántás, Boglárka, Biró-Süt, Tünde, Erostyák, János, Makkai, Géza, Sághy, Éva, Helyes, Zsuzsanna, Szőke, Éva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873636/
https://www.ncbi.nlm.nih.gov/pubmed/33584270
http://dx.doi.org/10.3389/fphar.2020.593319
_version_ 1783649425434869760
author Horváth, Ádám
Payrits, Maja
Steib, Anita
Kántás, Boglárka
Biró-Süt, Tünde
Erostyák, János
Makkai, Géza
Sághy, Éva
Helyes, Zsuzsanna
Szőke, Éva
author_facet Horváth, Ádám
Payrits, Maja
Steib, Anita
Kántás, Boglárka
Biró-Süt, Tünde
Erostyák, János
Makkai, Géza
Sághy, Éva
Helyes, Zsuzsanna
Szőke, Éva
author_sort Horváth, Ádám
collection PubMed
description Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingomyelin and gangliosides. We earlier showed that lipid raft disruption inhibits TRPV1 and TRPA1 functions in primary sensory neuronal cultures. Here we investigated the effects of sphingomyelinase (SMase) cleaving membrane sphingomyelin and myriocin (Myr) prohibiting sphingolipid synthesis in mouse pain models of different mechanisms. SMase (50 mU) or Myr (1 mM) pretreatment significantly decreased TRPV1 activation (capsaicin)-induced nocifensive eye-wiping movements by 37 and 41%, respectively. Intraplantar pretreatment by both compounds significantly diminished TRPV1 stimulation (resiniferatoxin)-evoked thermal allodynia developing mainly by peripheral sensitization. SMase (50 mU) also decreased mechanical hyperalgesia related to both peripheral and central sensitizations. SMase (50 mU) significantly reduced TRPA1 activation (formalin)-induced acute nocifensive behaviors by 64% in the second, neurogenic inflammatory phase. Myr, but not SMase altered the plasma membrane polarity related to the cholesterol composition as shown by fluorescence spectroscopy. These are the first in vivo results showing that sphingolipids play a key role in lipid raft integrity around nociceptive TRP channels, their activation and pain sensation. It is concluded that local SMase administration might open novel perspective for analgesic therapy.
format Online
Article
Text
id pubmed-7873636
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78736362021-02-11 Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation Horváth, Ádám Payrits, Maja Steib, Anita Kántás, Boglárka Biró-Süt, Tünde Erostyák, János Makkai, Géza Sághy, Éva Helyes, Zsuzsanna Szőke, Éva Front Pharmacol Pharmacology Transient Receptor Potential (TRP) Vanilloid 1 and Ankyrin 1 (TRPV1, TRPA1) cation channels are expressed in nociceptive primary sensory neurons, and integratively regulate nociceptor and inflammatory functions. Lipid rafts are liquid-ordered plasma membrane microdomains rich in cholesterol, sphingomyelin and gangliosides. We earlier showed that lipid raft disruption inhibits TRPV1 and TRPA1 functions in primary sensory neuronal cultures. Here we investigated the effects of sphingomyelinase (SMase) cleaving membrane sphingomyelin and myriocin (Myr) prohibiting sphingolipid synthesis in mouse pain models of different mechanisms. SMase (50 mU) or Myr (1 mM) pretreatment significantly decreased TRPV1 activation (capsaicin)-induced nocifensive eye-wiping movements by 37 and 41%, respectively. Intraplantar pretreatment by both compounds significantly diminished TRPV1 stimulation (resiniferatoxin)-evoked thermal allodynia developing mainly by peripheral sensitization. SMase (50 mU) also decreased mechanical hyperalgesia related to both peripheral and central sensitizations. SMase (50 mU) significantly reduced TRPA1 activation (formalin)-induced acute nocifensive behaviors by 64% in the second, neurogenic inflammatory phase. Myr, but not SMase altered the plasma membrane polarity related to the cholesterol composition as shown by fluorescence spectroscopy. These are the first in vivo results showing that sphingolipids play a key role in lipid raft integrity around nociceptive TRP channels, their activation and pain sensation. It is concluded that local SMase administration might open novel perspective for analgesic therapy. Frontiers Media S.A. 2021-01-27 /pmc/articles/PMC7873636/ /pubmed/33584270 http://dx.doi.org/10.3389/fphar.2020.593319 Text en Copyright © 2021 Horváth, Payrits, Steib, Kántás, Biró-Süt, Erostyák, Makkai, Sághy, Helyes and Szőke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Horváth, Ádám
Payrits, Maja
Steib, Anita
Kántás, Boglárka
Biró-Süt, Tünde
Erostyák, János
Makkai, Géza
Sághy, Éva
Helyes, Zsuzsanna
Szőke, Éva
Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title_full Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title_fullStr Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title_full_unstemmed Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title_short Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation
title_sort analgesic effects of lipid raft disruption by sphingomyelinase and myriocin via transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 ion channel modulation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873636/
https://www.ncbi.nlm.nih.gov/pubmed/33584270
http://dx.doi.org/10.3389/fphar.2020.593319
work_keys_str_mv AT horvathadam analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT payritsmaja analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT steibanita analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT kantasboglarka analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT birosuttunde analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT erostyakjanos analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT makkaigeza analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT saghyeva analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT helyeszsuzsanna analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation
AT szokeeva analgesiceffectsoflipidraftdisruptionbysphingomyelinaseandmyriocinviatransientreceptorpotentialvanilloid1andtransientreceptorpotentialankyrin1ionchannelmodulation